Utilization of lysolecithin by Landschütz ascites tumor in vivo and in vitro.
D000818:Animals; D001202:Ascitic Fluid; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D005227:Fatty Acids / Q000494:pharmacology; D066298:In Vitro Techniques; D008244:Lysophosphatidylcholines / Q000378:metabolism*; D008297:Male; D051379:Mice; D010169:Palmitic Acids / Q000494:pharmacology; D010740:Phospholipases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010759:Phosphorus Isotopes; D013501:Surface-Active Agents / Q000494:pharmacology
D002247:Carbon Isotopes; D005227:Fatty Acids; D008244:Lysophosphatidylcholines; D010169:Palmitic Acids; D010759:Phosphorus Isotopes; D013501:Surface-Active Agents; D010740:Phospholipases